Literature DB >> 12445729

A simple method for accurate quantification of complement receptor 1 on erythrocytes preserved by fixing or freezing.

I A Cockburn1, B Donvito, J H M Cohen, J A Rowe.   

Abstract

The mean number of complement receptor 1 (CR1) molecules on erythrocytes differs between normal individuals within the range of 100-1000 molecules per cell. In some disease states such as systemic lupus erythematosus (SLE), acquired immune deficiency syndrome (AIDS), insulin-dependent diabetes mellitus and malaria, erythrocyte CR1 levels are reduced and CR1 function may be impaired. Current methods for determining erythrocyte CR1 levels by flow cytometry require the use of freshly drawn blood samples because CR1 is lost from erythrocytes during storage. In order to facilitate field studies of associations between erythrocyte CR1 levels and disease, we have developed and validated an assay to quantify CR1 on both healthy and diseased erythrocytes that have been fixed in 5% formaldehyde or frozen in glycerol. These methods enable blood samples to be collected in areas lacking the facilities for flow cytometry and stored for later accurate quantification of CR1. Such procedures will be of particular benefit for future investigations of erythrocyte CR1 expression level and malaria susceptibility.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12445729     DOI: 10.1016/s0022-1759(02)00368-x

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  11 in total

1.  Dual role of erythrocyte complement receptor type 1 in immune complex-mediated macrophage stimulation: implications for the pathogenesis of Plasmodium falciparum malaria.

Authors:  M Odera; W Otieno; C Adhiambo; J A Stoute
Journal:  Clin Exp Immunol       Date:  2011-11       Impact factor: 4.330

2.  Erythrocyte complement receptor 1 (CR1) expression level is not associated with polymorphisms in the promoter or 3' untranslated regions of the CR1 gene.

Authors:  I A Cockburn; J A Rowe
Journal:  Int J Immunogenet       Date:  2006-02       Impact factor: 1.466

3.  STEVOR is a Plasmodium falciparum erythrocyte binding protein that mediates merozoite invasion and rosetting.

Authors:  Makhtar Niang; Amy Kristine Bei; Kripa Gopal Madnani; Shaaretha Pelly; Selasi Dankwa; Usheer Kanjee; Karthigayan Gunalan; Anburaj Amaladoss; Kim Pin Yeo; Ndeye Sakha Bob; Benoit Malleret; Manoj Theodore Duraisingh; Peter Rainer Preiser
Journal:  Cell Host Microbe       Date:  2014-07-09       Impact factor: 21.023

4.  Reduced immune complex binding capacity and increased complement susceptibility of red cells from children with severe malaria-associated anemia.

Authors:  Boaz O Owuor; Collins O Odhiambo; Walter O Otieno; Christine Adhiambo; Dominic W Makawiti; José A Stoute
Journal:  Mol Med       Date:  2008 Mar-Apr       Impact factor: 6.354

5.  A human complement receptor 1 polymorphism that reduces Plasmodium falciparum rosetting confers protection against severe malaria.

Authors:  Ian A Cockburn; Margaret J Mackinnon; Angela O'Donnell; Stephen J Allen; Joann M Moulds; Moses Baisor; Moses Bockarie; John C Reeder; J Alexandra Rowe
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-23       Impact factor: 11.205

6.  Mechanistic Studies of the Negative Epistatic Malaria-protective Interaction Between Sickle Cell Trait and α+thalassemia.

Authors:  D Herbert Opi; Lucy B Ochola; Metrine Tendwa; Bethsheba R Siddondo; Harold Ocholla; Harry Fanjo; Ashfaq Ghumra; David J P Ferguson; J Alexandra Rowe; Thomas N Williams
Journal:  EBioMedicine       Date:  2014-11-01       Impact factor: 8.143

7.  No Evidence that Knops Blood Group Polymorphisms Affect Complement Receptor 1 Clustering on Erythrocytes.

Authors:  O V Swann; E M Harrison; D H Opi; E Nyatichi; A Macharia; S Uyoga; T N Williams; J A Rowe
Journal:  Sci Rep       Date:  2017-12-19       Impact factor: 4.379

8.  Increased deposition of C3b on red cells with low CR1 and CD55 in a malaria-endemic region of western Kenya: implications for the development of severe anemia.

Authors:  Collins O Odhiambo; Walter Otieno; Christine Adhiambo; Michael M Odera; José A Stoute
Journal:  BMC Med       Date:  2008-08-21       Impact factor: 8.775

9.  Red blood cell complement receptor one level varies with Knops blood group, α(+)thalassaemia and age among Kenyan children.

Authors:  D H Opi; S Uyoga; E N Orori; T N Williams; J A Rowe
Journal:  Genes Immun       Date:  2016-02-04       Impact factor: 2.676

10.  A reference document on Permissible Limits for solvents and buffers during in vitro antimalarial screening.

Authors:  Renugah Naidu; Gowtham Subramanian; Ying Bena Lim; Chwee Teck Lim; Rajesh Chandramohanadas
Journal:  Sci Rep       Date:  2018-10-08       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.